The Practice is committed to continuing research. All the studies have been assessed by the NHS and have full ethical approval.
The Practice receives funding for research from the South West Peninsula Clinical Research Network (part of the NHS) and from the individual studies that we take part in. The research team undergo regular training in taking informed consent from patients taking part in studies and the practice has Royal College of GPs Research Ready accreditation.
PRINCIPLE
Our practice is supporting vital COVID-19 research. As part of this, we are helping to carry out a national priority research study called PRINCIPLE.
If you have symptoms of COVID-19, are aged 65 or over, OR are aged 50-64 and have an existing health condition, you may be eligible to join this important study.
- If you would like to discuss taking part in PRINCIPLE, please contact us.
- Please click here for full details of this study
If you would like to know more about COVID-19 research and how you can contribute, please visit this website which is run by the National Institute for Health Research.
PROTECT
Over 40? Interested in brain health research?
Join the PROTECT study to take part in cutting edge research and help us prevent dementia in the future.
The ERICA Trial
We are inviting you to take part in a research project called: Electronic Risk Assessment for Cancer (ERICA) led by Professor Willie Hamilton at the University of Exeter Medical School.
GLAD
The Genetic Links to Anxiety and Depression (GLAD) Study, led by the National Institute of Health Research (NIHR) Mental Health BioResource and researchers at King’s College London, in collaboration with researchers at Ulster University, University of Edinburgh, and Cardiff University, is a project set up to support studies exploring risk factors for depression and/or anxiety.
Depression and anxiety are the most common mental health disorders worldwide. In the UK, 1 in 3 people will experience symptoms during their lifetime. The GLAD Study aims to better understand depression and anxiety in order to find effective treatments and improve the lives of people experiencing these disorders
SHAPE (shapeproject.eu)
SHAPE stands for Self-management and HeAlth Promotion in Early-stage dementia with e-learning for carers.
The aim of SHAPE is to enhance the people with dementia’s belief in their own abilities to adapt and manage living with dementia. SHAPE provides a course with ten weekly group sessions for people with dementia where the participants will learn about dementia, decision-making, social interaction and healthy behaviours. Their care partners get information through an e-learning programme.
Our practice takes part in Disease Surveillance
This practice is one of over 1900 practices in England and Wales contributing pseudonymised data for national research and surveillance. These data enable continuous monitoring of infections and diseases in the community and is used in ethically approved research. The Oxford RCGP RSC is the main source of information for UK Health Security Agency (UKHSA) and helps with prediction and management of flu outbreaks and pandemics.
Providing pseudonymised data does not affect patients, their care or privacy however if you no longer wish to allow your information to be used, please speak to your GP.
The pseudonymised data, extracted by information service providers, Wellbeing Software and Egton Medical Information Systems are processed within the private and secure network of the Clinical Informatics and Health Outcomes Research Group at University of Oxford under a formal data sharing agreement. The pseudonymised data may be linked with other NHS data for analysis, including hospital episode statistics.
- Visit the Royal College of General Practitioners (RCGP) for more information
- Or Visit the ORCHID here
Our practice supporting the Athena Shingles Study
We want to find out if taking amitriptyline can prevent the persistent pain that some people get after shingles.
50 years or older and recently got shingles? You may be able to take part. Ask your doctor.
What is the MyMelanoma project about?
Every day in the UK, 50 people are diagnosed with melanoma of the skin, and melanoma continues to be of concern around the world, so around 220 people in the US, and 42 in Australia are diagnosed every day.
Despite considerable improvements in the treatment of melanoma in recent years much needs to be done to improve the quality of care internationally. MyMelanoma is designed to build a large anonymized database which researchers around the world will be able to use to understand how to deliver that improvement, in as fast a time as possible.
MyMelanoma is the most ambitious data collecting project ever performed internationally, linking data entered online by at least 20,000 patient participants with their data stored in the NHS.
As the project develops then the database will also include data generated from examination of blood, stool and tumour samples.
MyMelanoma is a unique collaboration between patients, the NHS, research scientists and NHS Digital, for the benefit of melanoma patients anywhere.